Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Accumulated Expenses (2017 - 2026)

InflaRx's Accumulated Expenses history spans 9 years, with the latest figure at -$595072.5 for Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 58.1% to -$595072.5 in Q1 2026 year-over-year; TTM through Mar 2026 was -$595072.5, a 58.1% increase, with the full-year FY2025 number at $1.4 million, down 38.57% from a year prior.
  • Accumulated Expenses hit -$595072.5 in Q1 2026 for InflaRx, down from $1.4 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for IFRX hit a ceiling of $2.2 million in Q4 2024 and a floor of -$1.4 million in Q1 2025.
  • Historically, Accumulated Expenses has averaged -$277004.3 across 5 years, with a median of -$521323.4 in 2024.
  • Biggest five-year swings in Accumulated Expenses: tumbled 1635.55% in 2022 and later surged 590.06% in 2023.
  • Tracing IFRX's Accumulated Expenses over 5 years: stood at -$65320.3 in 2022, then surged by 590.06% to $320111.5 in 2023, then surged by 589.23% to $2.2 million in 2024, then tumbled by 38.57% to $1.4 million in 2025, then tumbled by 143.91% to -$595072.5 in 2026.
  • Business Quant data shows Accumulated Expenses for IFRX at -$595072.5 in Q1 2026, $1.4 million in Q4 2025, and -$649617.0 in Q3 2025.